Skip to content
Spinnet Media

Zimbabwe Rejects ‘Lopsided’ American Healthcare Assistance Package Due to Information Fears

Medical aid image
The proposed American financial assistance would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has declined a major US health deal valued at $367m (£272m) over five years due to Washington's insistence on sensitive biological samples.

The decision came to light after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "unbalanced".

An official representative later stated that the United States was requesting genetic material for research and commercial purposes while was not willing to guarantee the resulting advantages from any future treatments.

"We must now begin the challenging and unfortunate task of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for more negotiations to find a agreement suitable to all parties so the country's vital HIV treatment initiative can be sustained.

Wider Implications

Zimbabwe's decision follows a similar situation in Kenya, where a high court suspended a related deal with the US after concerns were raised about the security of citizens' medical information.

After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and responsibility.

Based on statements, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.

"Effectively, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be accessible to our population should a future disease outbreak emerge."

National Interest and International Frameworks

He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending systems previously established via the international health agency.

Mangwana cited its Pathogen Access and Benefit Sharing system created to manage future pandemics.

"This system is intended to ensure that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to create them."

The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We are open to ongoing discussions with our American counterparts on how future co-operation might be arranged in a manner that honours the sovereignty and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist since a large portion of the country's HIV programmes were funded by external financing.

"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.

This impasse underscores the complex challenges between accepting crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.

DR
About the author

Daniel Richardson

A digital strategist with over 8 years of experience in SEO and content marketing, passionate about helping businesses thrive online.

Spinnet Media

Type to search articles.